[go: up one dir, main page]

BG106816A - Cyclic quaternary ammonium compounds - Google Patents

Cyclic quaternary ammonium compounds

Info

Publication number
BG106816A
BG106816A BG106816A BG10681602A BG106816A BG 106816 A BG106816 A BG 106816A BG 106816 A BG106816 A BG 106816A BG 10681602 A BG10681602 A BG 10681602A BG 106816 A BG106816 A BG 106816A
Authority
BG
Bulgaria
Prior art keywords
quaternary ammonium
ammonium compounds
cyclic quaternary
formula
compounds
Prior art date
Application number
BG106816A
Other languages
Bulgarian (bg)
English (en)
Inventor
Lewis CHOI
Gregory BEATCH
Clive PAGE
Original Assignee
Ucb Farchim S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Farchim S.A. filed Critical Ucb Farchim S.A.
Publication of BG106816A publication Critical patent/BG106816A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
BG106816A 1999-12-15 2002-06-12 Cyclic quaternary ammonium compounds BG106816A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2292351 1999-12-15
PCT/CA2000/001506 WO2001044192A1 (en) 1999-12-15 2000-12-15 Cyclic quaternary ammonium compounds

Publications (1)

Publication Number Publication Date
BG106816A true BG106816A (en) 2003-04-30

Family

ID=4164887

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106816A BG106816A (en) 1999-12-15 2002-06-12 Cyclic quaternary ammonium compounds

Country Status (19)

Country Link
US (1) US20030166629A1 (et)
EP (1) EP1278731A1 (et)
JP (1) JP2003516966A (et)
KR (1) KR20020074170A (et)
CN (1) CN1425005A (et)
AU (1) AU2334501A (et)
BG (1) BG106816A (et)
BR (1) BR0016431A (et)
CZ (1) CZ20022095A3 (et)
EE (1) EE200200314A (et)
HU (1) HUP0301686A2 (et)
IL (1) IL150179A0 (et)
IS (1) IS6417A (et)
MX (1) MXPA02006051A (et)
NO (1) NO20022870L (et)
PL (1) PL356032A1 (et)
WO (1) WO2001044192A1 (et)
YU (1) YU44102A (et)
ZA (1) ZA200205566B (et)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140097446A (ko) 2006-11-20 2014-08-06 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 통증 및 소양증 치료용 방법, 조성물 및 키트
MX2010009951A (es) * 2008-03-11 2011-09-01 Harvard College Metodos, composiciones y kits para tratar dolor y prurito.
US20120172429A1 (en) * 2009-07-10 2012-07-05 Woolf Clifford J Permanently charged sodium and calcium channel blockers as anti- inflammatory agents
US10130632B2 (en) 2012-11-27 2018-11-20 Beth Israel Deaconess Medical Center, Inc. Methods for treating renal disease
US10604809B2 (en) 2014-02-04 2020-03-31 Beth Israel Deaconess Medical Center, Inc. Methods and kits for the diagnosis and treatment of pancreatic cancer
JP6833811B2 (ja) * 2015-08-03 2021-02-24 プレジデント アンド フェローズ オブ ハーバード カレッジ 荷電イオンチャネル遮断薬及び使用方法
CN113924094A (zh) 2019-03-11 2022-01-11 诺西恩医疗公司 酯取代的离子通道阻滞剂及其使用方法
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
KR20210143791A (ko) 2019-03-11 2021-11-29 녹시온 테라퓨틱스 인코포레이티드 하전된 이온 채널 차단제 및 사용 방법
JP7678757B2 (ja) 2019-03-11 2025-05-16 ノシオン セラピューティクス,インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
WO2021091585A1 (en) 2019-11-06 2021-05-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
KR20230022830A (ko) 2020-03-11 2023-02-16 녹시온 테라퓨틱스 인코포레이티드 하전된 이온 채널 차단제 및 사용 방법
US12162851B2 (en) 2020-03-11 2024-12-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI58632C (fi) * 1978-02-07 1981-03-10 Orion Yhtymae Oy Foerfarande foer framstaellning av anilider med antitussiv verkan

Also Published As

Publication number Publication date
IL150179A0 (en) 2002-12-01
EP1278731A1 (en) 2003-01-29
IS6417A (is) 2002-06-12
EE200200314A (et) 2003-08-15
BR0016431A (pt) 2002-10-01
NO20022870L (no) 2002-08-14
MXPA02006051A (es) 2004-08-23
CZ20022095A3 (cs) 2003-02-12
NO20022870D0 (no) 2002-06-14
AU2334501A (en) 2001-06-25
HUP0301686A2 (hu) 2003-08-28
WO2001044192A1 (en) 2001-06-21
KR20020074170A (ko) 2002-09-28
CN1425005A (zh) 2003-06-18
ZA200205566B (en) 2003-11-17
US20030166629A1 (en) 2003-09-04
JP2003516966A (ja) 2003-05-20
YU44102A (sh) 2005-09-19
PL356032A1 (en) 2004-06-14

Similar Documents

Publication Publication Date Title
BG106816A (en) Cyclic quaternary ammonium compounds
GEP20094675B (en) Heteroaryl- tetra-hydropiperidyl compounds useful for treating or preventing pain
ATE516062T1 (de) Quaternäre ammoniumverbindungen enthaltende wasserfreie zusammensetzungen
ZA988826B (en) Acylsulfamoylbenzamides crop protection compositions comprising them and processes for their preparation
MY148652A (en) New crystalline form of a triazolo(4,5-d)pyrimidine compound
HUP9901199A2 (hu) Neurotranszmitter újrafelvételt gátló tropánszármazékok és eljárás előállításukra, e vegyületeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
MY127144A (en) New anticholinergics which may be used as medicaments as well as processes for preparing them
NZ331457A (en) Methoxybenzophenone compounds, a process for their preparation and a method involving them for combating fungal growth
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
GB0011203D0 (en) Chemical compounds
DE60112330D1 (en) Pyrazolopyridinderivate
PL345397A1 (en) Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process
ATE531375T1 (de) Formulierung enthaltend phosphatderivate von elektronentransfermitteln
PL301576A1 (en) Novel hiv protease inhibitors, method of obtaining such inhibitors, pharmaceutical preparation and novel initial compounds
FR2757857B1 (fr) Diselenures et selenosulfures aromatiques, leur preparation et leurs utilisations, notamment therapeutiques
WO1999050269A3 (de) Porphyrine und ihre verwendung als phptosensitizer
EA200000431A2 (ru) Новые замещенные димерные соединения, способ их получения и фармацевтические композиции, содержащие их
YU44202A (sh) Kvaternerne soli n-substituisanih cikiličnih ili ne- cikličnih amina kao farmaceutski preparati
HUT63613A (en) Insecticidal and acaricidal compositions comprising n-alkanoyl-amino-methyl and n-aroyl-aminomethylpyrrole compounds, as well as process for producing the active ingredients
EP1122252A4 (en) CONDENSED HEREROCYCLIC NITROGEN COMPOUNDS; MANUFACTURING PROCESS AND AGENTS CONTAINING THEM
MXPA03010737A (es) Aril-8-azabiciclo(3.2.1) octanos para tratamiento de depresion.
GB0012795D0 (en) Organic compounds
DE69402004D1 (de) Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen
DE69917668D1 (de) Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung
ATE179424T1 (de) N-heteroaryl substituierte propanamid-derivate brauchbar zur behandlung cardiovascularer krankheiten